Literature DB >> 22527667

[Endoscopic and percutaneous intervention in the long-term treatment of benign biliary stenosis. A 71-year-old patient with cholestasis following radiotherapy].

P Klare1, A Weber, M Dobritz, P Born, R Füllner, R M Schmid, S von Delius.   

Abstract

Benign biliary stenosis can have various causes and requires differentiation from disorders caused by malignant disease. Treatment of benign stenosis is often difficult and includes treatment modalities such as endoscopic, percutaneous or surgical interventions. Exact knowledge of the etiology and localization of the stenosis is essential when selecting the appropriate method of treatment. Here we present the case of a 71-year-old patient admitted to our hospital with cholangitis 13 years after undergoing radiotherapy of the renal bed due to hypernephroma of the right kidney. The patient was diagnosed with common bile duct stenosis due to the secondary effects of radiation, which is rarely reported in the literature. Our case covers a total treatment period of 15 years, enabling us to also discuss a viable sequence of treatment modalities in the treatment of benign bile duct stenosis.

Entities:  

Mesh:

Year:  2012        PMID: 22527667     DOI: 10.1007/s00108-012-3053-2

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  24 in total

1.  EUS-guided pancreatogastrostomy and pancreatobulbostomy for the treatment of pain in patients with pancreatic ductal dilatation inaccessible for transpapillary endoscopic therapy.

Authors:  Geneviève Tessier; Erwan Bories; Marianna Arvanitakis; Axel Hittelet; Christian Pesenti; Olivier Le Moine; Marc Giovannini; Jacques Devière
Journal:  Gastrointest Endosc       Date:  2007-02       Impact factor: 9.427

2.  Interventional EUS-guided cholangiography: evaluation of a technique in evolution.

Authors:  Michel Kahaleh; Alfredo J Hernandez; Jeffrey Tokar; Reid B Adams; Vanessa M Shami; Paul Yeaton
Journal:  Gastrointest Endosc       Date:  2006-07       Impact factor: 9.427

3.  Plastic and metal stents for postoperative benign bile duct strictures: the best and the worst.

Authors:  J M Dumonceau; J Devière; M Delhaye; M Baize; M Cremer
Journal:  Gastrointest Endosc       Date:  1998-01       Impact factor: 9.427

4.  Long-term follow-up after biliary stent placement for postoperative bile duct stenosis.

Authors:  J J Bergman; L Burgemeister; M J Bruno; E A Rauws; D J Gouma; G N Tytgat; K Huibregtse
Journal:  Gastrointest Endosc       Date:  2001-08       Impact factor: 9.427

5.  Long-term results of endoscopic management of postoperative bile duct strictures with increasing numbers of stents.

Authors:  G Costamagna; M Pandolfi; M Mutignani; C Spada; V Perri
Journal:  Gastrointest Endosc       Date:  2001-08       Impact factor: 9.427

Review 6.  [Errors and danger in laparoscopic cholecystectomy].

Authors:  J R Siewert; H Feussner; M A Scherer; I B Brune
Journal:  Chirurg       Date:  1993-04       Impact factor: 0.955

Review 7.  Expandable metal stents for benign biliary disease.

Authors:  Mihir R Bakhru; Michel Kahaleh
Journal:  Gastrointest Endosc Clin N Am       Date:  2011-07

8.  Long-term outcome in patients with benign biliary strictures treated endoscopically with multiple stents.

Authors:  Peter Draganov; Brenda Hoffman; William Marsh; Peter Cotton; John Cunningham
Journal:  Gastrointest Endosc       Date:  2002-05       Impact factor: 9.427

9.  Long-term outcome of endoscopic and/or percutaneous transhepatic therapy in patients with biliary stricture after orthotopic liver transplantation.

Authors:  Andreas Weber; Christian Prinz; Carlos Gerngross; Leopold Ludwig; Wolfgang Huber; Bruno Neu; Matthias P Ebert; Alexander Meining; Hans Weidenbach; Roland M Schmid; Ewert Schulte-Frohlinde
Journal:  J Gastroenterol       Date:  2009-09-09       Impact factor: 7.527

10.  EUS-guided rendezvous drainage of obstructed biliary and pancreatic ducts: Report of 6 cases.

Authors:  Shawn Mallery; Jake Matlock; Martin L Freeman
Journal:  Gastrointest Endosc       Date:  2004-01       Impact factor: 9.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.